Your Article Summary
See Latest ArticlesRepeat prostate biopsy — when, where, and how
Urologic Oncology: Seminars and Original Investigations, 06/29/09
Presti JC - In a review of the indications and techniques in pts undergoing a repeat biopsy, it appears that in pts for whom repeat biopsies fail to identify cancer, yet clinical suspicion remains high, consideration for a saturation biopsy approach seems warranted.
Methods- Pts who have a persistently elevated or a rising PSA level following a prior negative prostate biopsy can be a stressful situation for both urologist and pt.
- In pts with a prior negative biopsy, assessing the adequacy of the initial biopsy is important.
- F/T PSA is currently the most useful marker in predicting cancer on repeat biopsy, although newer markers, such as PCA3, are promising.
- Repeat biopsies should include a minimum of 14 cores, the 12 cores recommended for an initial biopsy and 2 additional cores obtained from the right and left anterior apex.
Related Articles
Detection rate and factors predictive the presence of prostate cancer in patients undergoing ultrasonography-guided transperineal saturation biopsies of the prostate
BJU International, 11/06/09
Relevance Score: 70%
Caudal analgesia for prostate biopsy
Acta Anaesthesiologica Scandinavica, 11/18/09
Relevance Score: 69%
Gleason score and laterality concordance between prostate biopsy and prostatectomy specimens
International Braz J Urol, 11/03/09
Relevance Score: 69%
Exercise and Prostate Cancer Risk in a Cohort of Veterans Undergoing Prostate Needle Biopsy
The Journal of Urology, 10/19/09
Relevance Score: 69%
Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended
BJU International, 10/13/09
Relevance Score: 69%
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/18/09
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Patient Perceived Effectiveness of a New Male Sling as Treatment for Post-Prostatectomy Incontinence
The Journal of Urology, 12/18/09
Health-related quality of life in men with localized prostate cancer
International Journal of Urology, 12/18/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles
The Prostate, 12/18/09
Influence of Cytokine Gene Polymorphisms on Prostate-Specific Antigen Recurrence in Prostate Cancer after Radical Prostatectomy
Urologia Internationalis, 12/18/09
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/18/09